Invention Grant
- Patent Title: Anti-DPEP3 antibodies and methods of use
-
Application No.: US15331282Application Date: 2016-10-21
-
Publication No.: US09777071B2Publication Date: 2017-10-03
- Inventor: Laura Saunders , Deepti Rokkam , David Liu , Mandy Boontanrart
- Applicant: AbbVie Stemcentrx LLC
- Applicant Address: US IL North Chicago
- Assignee: ABBVIE STEMCENTRX LLC
- Current Assignee: ABBVIE STEMCENTRX LLC
- Current Assignee Address: US IL North Chicago
- Agency: Womble Carlyle Sandridge & Rice, LLP
- Main IPC: A61K39/00
- IPC: A61K39/00 ; C07K16/00 ; C07K16/28 ; C07K16/40 ; C07K16/30 ; A61K31/551 ; A61K47/48
Abstract:
Provided herein are novel anti-DPEP3 antibodies and antibody drug conjugates (ADC), including derivatives thereof, and methods of using the same to treat proliferative disorders.
Public/Granted literature
- US20170044271A1 NOVEL ANTI-DPEP3 ANTIBODIES AND METHODS OF USE Public/Granted day:2017-02-16
Information query
